Dexamethasone induced cardiac hypertrophy in newborn rats is accompanied by changes in myosin heavy chain phenotype and gene transcription.
about
Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosisEffects of triiodo-thyronine on angiotensin-induced cardiomyocyte hypertrophy: reversal of increased beta-myosin heavy chain gene expression[Neonatal hypertrophic cardiomyopathy of difficult etiologic diagnosis]Abrogation of Nrf2 impairs antioxidant signaling and promotes atrial hypertrophy in response to high-intensity exercise stress.Cardiac effects of a single course of antenatal betamethasone in preterm infants.A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids.Regulation of cardiac beta 1-adrenergic receptor transcription during the developmental transition.Dexamethasone promotes hypertrophy of H9C2 cardiomyocytes through calcineurin B pathway, independent of NFAT activation.Chronic alterations in ovine maternal corticosteroid levels influence uterine blood flow and placental and fetal growth.Long-term cardiovascular effects of neonatal dexamethasone treatment: hemodynamic follow-up by left ventricular pressure-volume loops in rats.Histopathological changes of the heart after neonatal dexamethasone treatment: studies in 4-, 8-, and 50-week-old rats.Dexamethasone-induced cardiac deterioration is associated with both calcium handling abnormalities and calcineurin signaling pathway activation.Neonatal glucocorticosteroid treatment causes systolic dysfunction and compensatory dilation in early life: studies in 4-week-old prepubertal rats.
P2860
Q28580617-765339B1-1155-456E-8BDB-285F869027E8Q29144220-E07CA1F4-423C-485C-8F3F-8F2965A37120Q35791934-3D57B935-4916-4C55-8F44-652EA9C45B68Q36769369-18B1F326-A4E6-4669-AFE6-9EF965C23393Q37168096-D676D5F4-3A68-4C61-A139-15696BF202C6Q37357796-A882A4B1-74BB-47FA-880F-DC5F0A1670D1Q38354732-A71A9585-F5DA-4C7C-9486-29771D4A800CQ38824086-EA4447D5-F5CE-490B-AA3E-5D780B612190Q44961793-D120BCB4-D975-47B2-B013-B97E3BEE5856Q46850932-4FC6F6C5-6BB0-4632-9F1B-BBFD08E05F9FQ46922194-2976E7C3-64AB-482B-A5FF-B92CF07BC1DDQ48288742-6F7B7325-5568-442C-BA8B-7D959055774FQ53853355-E7532581-D06C-492B-A74A-1C49BA986783
P2860
Dexamethasone induced cardiac hypertrophy in newborn rats is accompanied by changes in myosin heavy chain phenotype and gene transcription.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Dexamethasone induced cardiac ...... notype and gene transcription.
@ast
Dexamethasone induced cardiac ...... notype and gene transcription.
@en
type
label
Dexamethasone induced cardiac ...... notype and gene transcription.
@ast
Dexamethasone induced cardiac ...... notype and gene transcription.
@en
prefLabel
Dexamethasone induced cardiac ...... notype and gene transcription.
@ast
Dexamethasone induced cardiac ...... notype and gene transcription.
@en
P2093
P356
P1476
Dexamethasone induced cardiac ...... notype and gene transcription.
@en
P2093
P2888
P304
P356
10.1023/A:1007128300430
P577
2000-06-01T00:00:00Z
P6179
1018211864